MYPRO FOR MM Trademark

Trademark Overview

On Wednesday, February 27, 2019, a trademark application was filed for MYPRO FOR MM with the United States Patent and Trademark Office. The USPTO has given the MYPRO FOR MM trademark a serial number of 88318770. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 18, 2022. This trademark is owned by Celgene Corporation. The MYPRO FOR MM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing an on-line computer database featuring scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, pharmacology and biotechnology; scientific research consultation pertaining to clinical trials; providing scientific research information in the field of clinical trials
mypro for mm

General Information

Serial Number88318770
Word MarkMYPRO FOR MM
Filing DateWednesday, February 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Pseudo MarkMY PRO FOR MULTIPLE MYELOMA
Goods and ServicesProviding an on-line computer database featuring scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, pharmacology and biotechnology; scientific research consultation pertaining to clinical trials; providing scientific research information in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Monday, April 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 24, 2021SOU EXTENSION 3 GRANTED
Tuesday, August 24, 2021SOU EXTENSION 3 FILED
Tuesday, August 24, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 2 GRANTED
Monday, March 15, 2021SOU EXTENSION 2 FILED
Monday, March 15, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 15, 2020SOU EXTENSION 1 GRANTED
Tuesday, September 15, 2020SOU EXTENSION 1 FILED
Tuesday, September 15, 2020SOU TEAS EXTENSION RECEIVED
Saturday, September 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, September 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 12, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, September 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, September 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 22, 2020EXPARTE APPEAL TERMINATED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 13, 2019EXPARTE APPEAL TERMINATED
Friday, December 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019ASSIGNED TO LIE
Thursday, December 5, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, December 5, 2019EX PARTE APPEAL-INSTITUTED
Thursday, December 5, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 5, 2019EXPARTE APPEAL RECEIVED AT TTAB
Friday, June 7, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 7, 2019FINAL REFUSAL E-MAILED
Friday, June 7, 2019FINAL REFUSAL WRITTEN
Thursday, May 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2019NON-FINAL ACTION WRITTEN
Sunday, April 28, 2019ASSIGNED TO EXAMINER
Tuesday, March 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 2, 2019NEW APPLICATION ENTERED

Related Keywords

mypro scientific research information trials clinical field providing pertaining consultation consulting